Concepedia

Author

Achim Sauer

Boehringer Ingelheim (Germany)ORCID

Also Known As

A SAUER, A Sauer, A. Sauer, Achim Sauer

83

Publications

1.7K

Citations

17

H-Index

55

Concepts

All Affiliations

Boehringer Ingelheim (Germany)University of KonstanzBoehringer Ingelheim (United States)Evotec (Germany)University of Eastern Finland
AS

About

Achim Sauer is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

204

2

Biochemistry

3

3

64

3

Engineering

1

1

11

4

Health Sciences

1

1

47

5

Public Health

1

1

18

Achim Sauer

×

22

Publications

1.6K

Citations

17

H-Index

YearCitations

Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors

Rolf Grempler, Leo Thomas, Matthias Eckhardt,

Diabetes Obesity and Metabolism

2011

583

Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers

Thomas Härtung, W-D Döcke, Florian Gantner,

Blood

1995

277

In vivo selective inhibition of TRPC6 by antagonist BI 749327 ameliorates fibrosis and dysfunction in cardiac and renal disease

Brian L. Lin, Damian Matera, Julia F. Doerner,

Proceedings of the National Academy of Sciences

2019

143

Treatment with HC-070, a potent inhibitor of TRPC4 and TRPC5, leads to anxiolytic and antidepressant effects in mice

Stefan Just, Bertrand L. Chenard, Angelo Ceci,

PLoS ONE

2018

135

Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates

Clemens Braun, Atsushi Sakamoto, Holger Fuchs,

Molecular Pharmaceutics

2017

57

Control of Fecal Peritoneal Infection in Mice by Colony-Stimulating Factors

Johannes Barsig, Daniela S. Bundschuh, Thomas Härtung,

The Journal of Infectious Diseases

1996

50

Long‐term treatment with empagliflozin, a novel, potent and selective SGLT‐2 inhibitor, improves glycaemic control and features of metabolic syndrome in diabetic rats

Leo Thomas, Rolf Grempler, Matthias Eckhardt,

Diabetes Obesity and Metabolism

2011

47

A Bidirectional Permeability Assay for beyond Rule of 5 Compounds

Yunhai Cui, Cyril Désévaux, Ines Truebenbach,

Pharmaceutics

2021

30

Ocular metabolism and distribution of drugs in the rabbit eye: Quantitative assessment after intracameral and intravitreal administrations

Eva M. del Amo, Anam Hammid, Melanie Tausch,

International Journal of Pharmaceutics

2021

29

Overactivation of the Immune System by Translocated Bacteria and Bacterial Products

Thomas Härtung, Achim Sauer, C. Hermann,

Scandinavian Journal of Gastroenterology

1997

28

Page 1